Professor David Mackey is a world leader in the translation of genetic eye disease research into treatment. Gene discovery allows accurate diagnosis, predictive testing and genetically guided treatment. David has also evaluated the ethics and cost effectiveness of gene based testing. He is President of the International Society of Genetic Eye Disease and Retinoblastoma; a member of the NHMRC Human Genetics Advisory Committee; teacher and examiner for the Royal Australian and New Zealand College of Ophthalmologists; wrote the genetics chapters for the American Academy of Ophthalmology basic text books. He has trained ophthalmology registrars, fellows and supervises medical, Masters and PhD students.
Menu